Story thread · 2 reports / 2 sources

COSCIENS ACQUIRES NUALTIS CORP.

financialpost.com · 4dShare

TORONTO, ONTARIO, Sept. 10, 2026 (GLOBE NEWSWIRE) — COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“COSCIENS” or the “Company”) is pleased to announce the acquisition of Nualtis Corp. (“Nualtis”), a Montreal-based specialty pharmaceutical technology business focused primarily on proprietary oral thin-film drug delivery technologies, with applications for both human and animal health. The Company also […]

First report: COSCIENS ACQUIRES NUALTIS CORP. — markets.businessinsider.com, 4d